Integrated Wealth Concepts’s CureVac CVAC Stock Holding History

Integrated Wealth Concepts’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-15,000	Closed	-$41.5K	–	1919
2025 Q1	$41.5K	Buy	15,000 +3,000	+25%	+$10.4K	﹤0.01%	1705
2024 Q4	$40.9K	Hold	12,000	–	–	﹤0.01%	1691
2024 Q3	$35.3K	Buy	+12,000	New	+$39.5K	﹤0.01%	1649

Other funds holding CVAC

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Integrated Wealth Concepts's CVAC Position: Q2 2025 in Review

Integrated Wealth Concepts sold out of CureVac (CVAC) in Q2 2025, closing a stake of 15,000 shares — an estimated $41.5K sold.

Integrated Wealth Concepts first reported a position in CVAC in Q3 2024 and held it in 3 quarters. The position peaked at $41.5K in Q1 2025. 91 funds tracked by Wall St. Rank hold CVAC as of Q2 2025.

Integrated Wealth Concepts reported no remaining CureVac position as of Q2 2025 after selling out during the quarter.
Integrated Wealth Concepts sold 15,000 CureVac shares in Q2 2025, an estimated $41.5K.
Integrated Wealth Concepts first reported a position in CureVac in Q3 2024 and held it in 3 quarters.
Integrated Wealth Concepts's CureVac position peaked at $41.5K in Q1 2025.
91 funds tracked by Wall St. Rank held CureVac as of Q2 2025.

Based on Integrated Wealth Concepts's 13F filing for Q2 2025, filed 14 Aug 2025.